Aurobindo Pharma Limited Stock Forecast
Aurobindo Pharma Limited stock upgraded from Buy Candidate to Strong Buy Candidate after Monday trading session.
(Updated on May 06, 2024)
The Aurobindo Pharma Limited stock price gained 1.00% on the last trading day (Monday, 6th May 2024), rising from ₹1,151.65 to ₹1,163.20. During the last trading day the stock fluctuated 2.66% from a day low at ₹1,141.60 to a day high of ₹1,172.00. The price has risen in 7 of the last 10 days and is up by 8.08% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 482 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately ₹1.49 billion.
The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at ₹1,186.70 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.14% during the next 3 months and, with a 90% probability hold a price between ₹1,202.54 and ₹1,342.68 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AUROPHARMA.NS Signals & Forecast
The Aurobindo Pharma Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹1,151.61 and ₹1,094.15. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, March 19, 2024, and so far it has risen 17.45%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Aurobindo Pharma Limited stock
On the downside, the stock finds support just below today's level from accumulated volume at ₹1,018.65 and ₹996.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aurobindo Pharma Limited finds support just below today's level at ₹1,018.65. If this is broken, then the next support from accumulated volume will be at ₹996.10 and ₹994.25.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹30.40 (2.66%) between high and low. For the last week, the stock has had daily average volatility of 1.77%.
Our recommended stop-loss: ₹1,121.56 (-3.58%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 31 days ago.)
Trading Expectations (AUROPHARMA.NS) For The Upcoming Trading Day Of Tuesday 7th
For the upcoming trading day on Tuesday, 7th we expect Aurobindo Pharma Limited to open at ₹1,158.93, and during the day (based on 14 day Average True Range), to move between ₹1,135.56 and ₹1,190.84, which gives a possible trading interval of +/-₹27.64 (+/-2.38%) up or down from last closing price. If Aurobindo Pharma Limited takes out the full calculated possible swing range there will be an estimated 4.75% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ ₹1,018.65, some ₹144.55 (12.43%) from the current price of ₹1,163.20, our system finds the risk reward attractive.
Is Aurobindo Pharma Limited stock A Buy?
Aurobindo Pharma Limited holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score: 6.593 Strong Buy Candidate Upgraded
Predicted Opening Price for Aurobindo Pharma Limited of Tuesday, May 7, 2024
| Fair opening price May 7, 2024 | Current price |
|---|---|
| ₹1,158.93 ( 0.367%) | ₹1,163.20 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AUROPHARMA.NS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1,189.33 | 2.25 % | |
| R2 | 1,177.72 | 1.25 % | ||
| R1 | 1,170.55 | 0.632 % | ||
| Current price: | 1,163.20 | |||
| Support | S1 | 1,147.32 | -1.37 % | |
| S2 | 1,140.15 | -1.98 % | ||
| S3 | 1,128.53 | -2.98 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0 | . | |
| R2 | 0 | . | ||
| R1 | 0 | . | ||
| Current price | 1,163.20 | |||
| Support | S1 | 1,018.65 | -12.43% | |
| S2 | 996.10 | -14.37% | ||
| S3 | 994.25 | -14.52% |
AUROPHARMA Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 20, 2024 | Feb 20, 2024 | Mar 04, 2024 | ₹1.50 | 0.138% |
| 2 | Nov 20, 2023 | Nov 20, 2023 | Nov 20, 2023 | ₹3.00 | 0.301% |
| 3 | Feb 17, 2023 | Feb 17, 2023 | Feb 17, 2023 | ₹3.00 | 0.634% |
| 4 | Jun 06, 2022 | Jun 06, 2022 | Jun 06, 2022 | ₹4.50 | 0.86% |
| 5 | Feb 18, 2022 | Feb 18, 2022 | Feb 18, 2022 | ₹1.50 | 0.228% |
FAQ
Click here for our free guide on how to buy Aurobindo Pharma Limited Stock.
